Term Name: | 1-[(13Z,16Z)-docosadienoyl]-2-linoleoyl-sn-glycero-3-phospho-1D-myo-inositol |
---|---|
Synonyms: | (2R)-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]-2-{[(9Z,12Z)-octadeca-9,12-dienoyl]oxy}propyl (13Z,16Z)-docosa-13,16-dienoate, 1-(13Z,16Z-docosadienoyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1'-myo- inositol), 1-(13Z,16Z-Docosadienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-myo-inositol), 1-[(13Z,16Z)-docosadienoyl]-2-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phospho-1D-myo-inositol, 1-Docosadienoyl-2-linoleoyl-sn-glycero-3-phosphoinositol, Phosphatidylinositol(22:2/18:2), Phosphatidylinositol(22:2n6/18:2n6), Phosphatidylinositol(22:2w6/18:2w6), Phosphatidylinositol(40:4), PI(22:2(13Z,16Z)/18:2(9Z,12Z)), PI(22:2/18:2), PI(22:2n6/18:2n6), PI(22:2w6/18:2w6), PI(40:4), PIno(22:2/18:2), PIno(22:2n6/18:2n6), PIno(22:2w6/18:2w6), PIno(40:4) |
Definition: | A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (13Z,16Z)-docosadienoyl and linoleoyl respectively. |
Ontology: | ChEBI [CHEBI:89245] ( EBI ) |